Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma

被引:49
作者
Koo, SH
Ihm, CH
Kwon, KC
Park, JW
Kim, JM
Kong, G
机构
[1] Chungnam Natl Univ Hosp, Dept Clin Pathol, Taejon 301040, South Korea
[2] Chungnam Natl Univ Hosp, Dept Pathol, Taejon 301040, South Korea
[3] Hanyang Univ, Dept Pathol, Seoul 133791, South Korea
关键词
D O I
10.1016/S0165-4608(01)00460-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the following study, we used comparative genomic hybridization (CGH) to screen and compare for genetic alterations of hepatocellular carcinoma (HCC) and intrahepatic choalgiocarcinoma (ICC). The studies showed distinctive features of genetic alterations between the two tumors. Characteristic abnormal changes for HCC were 1q gain and loss of 4q, 10q and 13q regions. In contrast, gains of 5p, 7p, 13q and 20q were more predominant in ICC. Losses of 16q, 17p, and 18q, and gain of 8q region showed a similar high frequency of incidence in both tumors, The most striking and different findings were 1q amplification in HCC and 20q gain in ICC. Our data indicate that ICC shows the pattern of genetic alteration,., similar to pancreatic and colorectal cancers. This suggests that the genetic alterations in tumorigenesis show a similar pattern depending on the origin of cells, not the organ. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:22 / 28
页数:7
相关论文
共 60 条
[1]   AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].
Anzick, SL ;
Kononen, J ;
Walker, RL ;
Azorsa, DO ;
Tanner, MM ;
Guan, XY ;
Sauter, G ;
Kallioniemi, OP ;
Trent, JM ;
Meltzer, PS .
SCIENCE, 1997, 277 (5328) :965-968
[2]  
ARMENGOL G, 1998, BRIT J CANCER, V75, P1403
[3]  
Boige V, 1997, CANCER RES, V57, P1986
[4]   Chromosome 1p aberrations are frequent in human primary hepatocellular carcinoma [J].
Chen, HL ;
Chen, YC ;
Chen, DS .
CANCER GENETICS AND CYTOGENETICS, 1996, 86 (02) :102-106
[5]   Positional cloning of ZNF217 and NABC1:: Genes amplified at 20q13.2 and overexpressed in breast carcinoma [J].
Collins, C ;
Rommens, JM ;
Kowbel, D ;
Godfrey, T ;
Tanner, M ;
Hwang, S ;
Polikoff, D ;
Nonet, G ;
Cochran, J ;
Myambo, K ;
Jay, KE ;
Froula, J ;
Cloutier, T ;
Kuo, WL ;
Yaswen, P ;
Dairkee, S ;
Giovanola, J ;
Hutchinson, GB ;
Isola, J ;
Kallioniemi, OP ;
Palazzolo, M ;
Martin, C ;
Ericsson, C ;
Pinkel, D ;
Albertson, D ;
Li, WB ;
Gray, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8703-8708
[6]   LOSS OF CONSTITUTIONAL HETEROZYGOSITY ON CHROMOSOME-5 AND CHROMOSOME-17 IN CHOLANGIOCARCINOMA [J].
DING, SF ;
DELHANTY, JDA ;
BOWLES, L ;
DOOLEY, JS ;
WOOD, CB ;
HABIB, NA .
BRITISH JOURNAL OF CANCER, 1993, 67 (05) :1007-1010
[7]   High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors [J].
Fasani, P ;
Sangiovanni, A ;
De Fazio, C ;
Borzio, M ;
Bruno, S ;
Ronchi, G ;
Del Ninno, E ;
Colombo, M .
HEPATOLOGY, 1999, 29 (06) :1704-1707
[8]   IDENTIFICATION OF A CHROMOSOME-18Q GENE THAT IS ALTERED IN COLORECTAL CANCERS [J].
FEARON, ER ;
CHO, KR ;
NIGRO, JM ;
KERN, SE ;
SIMONS, JW ;
RUPPERT, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
THOMAS, G ;
KINZLER, KW ;
VOGELSTEIN, B .
SCIENCE, 1990, 247 (4938) :49-56
[9]  
Forus A, 1996, CYTOGENET CELL GENET, V72, P148
[10]  
Fukushige S, 1997, GENE CHROMOSOME CANC, V19, P161, DOI 10.1002/(SICI)1098-2264(199707)19:3<161::AID-GCC5>3.0.CO